InVivium Capital
Venture capitalChicago · Seed–Late Stage · 6 people tracked
Also known as INVIVIUM CAPITAL MANAGEMENT, LLC
Investment thesis
InVivium Capital invests in transformative life sciences and healthcare innovation. The firm believes the healthcare industry is undergoing dramatic change that creates significant opportunity for groundbreaking innovation to meaningfully improve lives, health, and the quality of care people receive. Its stated mission is to work closely alongside exceptional founders and teams to bring transformational technologies to life.
Source: firm website, verified Aug 3, 2026.
Team · 6 people
from the firm's website
What they invest in
from 5 of 10 portfolio companiesBiotech ×5Digital Health ×1Medical Devices ×1Mental Health ×1
HQs:United States×5
Investments · 10 tracked
founders shown can be your intro pathAlto Neuroscience is a precision psychiatry company developing personalized drug treatments for people with neuropsychiatric conditions, using neuroscience research and clinical data to match patients to appropriate therapies.
BiotechDigital HealthMental HealthMountain View, US
Adam Savitz(Executive Officer)Amit Etkin(Founder)Nicholas C. Smith(Executive Officer)Gwill York(Director)Husseini Manji(Director)Christopher Nixon Cox(Director)
Board seatMichael Liang· per SEC Form D
A biotechnology company developing targeted therapies for rare respiratory diseases.
Avalyn Pharma develops a nebulized inhalation treatment for pulmonary fibrosis designed to improve tolerability compared to existing oral therapies by directly delivering the drug to the lungs.
BiotechMedical Devices
Lyn Baranowski(CEO)in
San Mateo, US
Board seatAmy Len Kobe· per SEC Form D · $50M raise · filed Nov 2021
A biotechnology company developing a ground-breaking platform of therapeutics called GEM-DIMERs.
BiotechBurlingame, US
Harold E. Selick, PhD(Executive Officer, Director)Miriam Siekevitz(Executive Officer)Daniel J. Capon(Director)Malcolm L. Gefter(Director)William D. Unger(Director)Samuel Saks(Director)
A biotechnology company developing a pipeline of first-in-class, pan cancer therapies.
BiotechSan Diego, US
Court Turner(Executive Officer, Director)Kevin Li, Ph.D.(Director)Lev Becker, Ph.D.(Director)
A biotechnology company developing a next generation, fully recombinant botulinum toxin.
BiotechLincoln, US
Tom Shehab(Director)Fred Robertson(Director)Tao Lin(Director)John P. Murphy(Executive Officer, Director)Fernando Pacheco(Director)Mukund Srinivasan(Executive Officer)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does InVivium Capital invest at?
- InVivium Capital invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does InVivium Capital focus on?
- InVivium Capital focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is InVivium Capital located?
- InVivium Capital is headquartered in Chicago, US.
Similar investors
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
Lumira Ventures is a North American life sciences venture capital firm that partners with mission-driven entrepreneurs to build companies developing and commercializing healthcare products for patients.
OrbiMed is a global healthcare-focused investment firm providing financing and operational support to companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
Foresite Capital is a multi-stage investment firm focused on healthcare and life sciences, backing companies across all stages of growth. It applies a data science-driven approach to invest in businesses leveraging biology and big data to transform healthcare.